NEXT Oncology Dallas — Irving, Texas

NEXT Oncology Dallas is a clinical research site located in Irving, Texas, United States 75039.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

NEXT Oncology Dallas has participated in 8 clinical trials with 8 currently active.

Therapeutic areas: Advanced Solid Tumor, NSCLC (Non-small Cell Lung Cancer), Renal Cancer.

Sponsors: Nuvectis Pharma, Inc., Revolution Medicines, Inc., Georgiamune Inc.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Oncology Dallas?

NEXT Oncology Dallas has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Oncology Dallas conducted?

NEXT Oncology Dallas has 8 clinical trials on record, with 8 currently active. Their work covers Advanced Solid Tumor, NSCLC (Non-small Cell Lung Cancer), Renal Cancer.

Is NEXT Oncology Dallas accredited by Crixeo Health?

Yes — NEXT Oncology Dallas holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about NEXT Oncology Dallas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.